BATTELLE'S DR. HERBERT BRESLER TO SPEAK AT 2006 REGENERATE WORLD CONGRESS
April 24, 2006

BATTELLE'S DR. HERBERT BRESLER TO SPEAK AT 2006 REGENERATE WORLD CONGRESS

Columbus, Ohio--Herbert Bresler will discuss the challenges of translating cell- and tissue-based therapies into successful products as part of the 2006 Regenerate World Congress on Tissue Engineering and Regenerative Medicine in Pittsburgh this week.

According to Dr. Bresler, the move from laboratory to market cannot occur without thoughtful development of manufacturing capabilities.

"A greater awareness is needed in the research and development community of the 'cliff' that awaits successful lab-based processes when faced with the challenges of simultaneously attaining commercial scale and regulatory rigor," Dr. Bresler says.

Dr. Bresler's presentation will kick off the Thursday sessions and set the stage for the final day of the Regenerate World Congress, and the first day of the 2006 Society for Biomaterials Annual Meeting and Exposition, which will be held at the same location. The presentation will summarize some of the major challenges facing regenerative medicine companies and will discuss a systematic approach to addressing those challenges.

The Regenerate World Congress is the leading conference on tissue engineering and regenerative technologies. The 2006 Congress focuses on tissue engineering and regenerative medicine approaches to restoring the function of damaged or diseased tissues and organs. The event also will explore technologies and broader cross-cutting challenges facing this emerging field of biomedicine. The event is designed for those engaged or interested in the fields of cellular therapies, medical devices and artificial organs, biomaterials, bioengineering, and clinical translation.

Dr. Bresler is Chief Scientist for Health & Life Sciences at Battelle. Battelle uses its unique combination of world-class medical device engineering, comprehensive biotechnology capabilities, and extensive experience in pre-clinical and clinical product development to help companies design and develop customized, integrated, closed manufacturing systems. Its solutions enable consistent clinical trial and commercial scale production and delivery of cell-based therapies and tissue-engineered products.

Battelle is headquartered in Columbus, Ohio, and, with the national labs it manages or co-manages, oversees 19,000 staff members and conducts $3.4 billion in annual research and development. For more information, visit www.battelle.org/healthcare/html/cellther.stm or contact Battelle Media Relations Manager Mark Berry at (614) 424-5544 or at berrym@battelle.org.

What: 2006 Regenerate World Congress on Tissue Engineering and Regenerative Medicine

When: April 25-27

Where: Westin Convention Center, Pittsburgh, Pennsylvania

On the Web: www.regenerate-online.com.